Craft

Ulisse BioMed

Stock Price

€0.9

2024-10-29

Market Capitalization

€20.7 M

2024-10-29

Revenue

€768 K

FY, 2024

Ulisse BioMed Summary

Company Summary

Overview
Ulisse BioMed is a healthcare biotech company that provides diagnostic platforms and products. It offers NanoHybrid, a biological drug monitoring platform, and molecular diagnostic assays. The company also provides product design, development, and manufacturing services.
Type
Public
Status
Active
Founded
2015
HQ
Udine, IT | view all locations
Website
https://www.ulissebiomed.com/it/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Udine, Friuli-Venezia Giulia HQ

    Italy

    Via Cavour, 20

Ulisse BioMed Financials

Summary Financials

Revenue (H1, 2025)
€529.0K
Gross profit (H1, 2025)
€3.0K
Net income (H1, 2025)
(€2.4M)
Cash (H1, 2025)
€1.1M
EBIT (H1, 2025)
(€2.4M)
Enterprise value
$20.6M

Footer menu